]>
IRCT20161210031328N9 IRCT 2019-04-10 Arak University of Medical Sciences The effect of autologous serum drops on keratopathy in patients hospitalized in intensive care unit Effect of autologous serum drop on the occurrence of exposure keratopathy in patients hospitalized intensive care units 2018-12-11 anticipated 44 Complete https://irct.ir/trial/35151 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: One of the eyes is cared with "A" and the other with "B" care methods. Coin throwing is done to determine the care method in each eye. Therefore, in some patients, the left eye, and in some patients, the right eye is cared with the "B" method, and so the "A" care is done both in the right eye and in the left eye of the patients. In other words, care "A" care method is considered as a control group and a "B" care method as an intervention group. N/A Keratopathy. Intervention 1: Intervention group: The right eye will be considered as intervention group. In addition to routine care, autologous serum drops are cast in the right eye every six hours. In order to provide an autologous serum, 10 to 20 ml of blood will be taken from the patient and according to the standard protocol in the laboratory of Valiasr Hospital in Arak, six sterile drops are prepared. Intervention 2: Control group: The left eye of patients will be considered as control group. In this group, routine care will be done on the eye. Yes - There is a plan to make this available What will be shared: Part of the data, such as information on the main outcome and the demographic information, can be shared. When: 36 months after publishing of results. To whom: Researchers in academic and scientific institutions. Conditions: In order to utilize scientific purposes and mention the source used. Where to obtain: Dr. Mahboubeh Sajjadi E-mail address: sajadimahbobeh@yahoo.com How to obtain: After receiving the email, the information will be sent within 2 to 3 working days. Comments:
public Mahbobeh Sajadi
Arak University of Medical Sciences, Basij Sq., Sardasht Region
Arak Iran (Islamic Republic of) 3819693345 +98 86 3417 3505 sajadimahbobeh@yahoo.com Arak University of Medical Sciences scientific Sina Dehghan
Arak University of Medical Sciences, Basij Sq., Sardasht Region
Arak Iran (Islamic Republic of) 3819693345 +98 86 3417 3505 sina.dehghan.acns@gmail.com Arak University of Medical Sciences Iran (Islamic Republic of) Hospitalization in intensive care unit 16 - 65 years old Signing the consent form Awareness score less than 10 according to Glasgow Coma Scale No history of eye disease before hospitalization Non-traumatic face and eye No history of consumption of ointment and ocular drops before hospitalization 16 years 65 years Both Unwillingness to participating in the study H18.9 Unspecified disorder of cornea Prevention Prevention Intervention group: The right eye will be considered as intervention group. In addition to routine care, autologous serum drops are cast in the right eye every six hours. In order to provide an autologous serum, 10 to 20 ml of blood will be taken from the patient and according to the standard protocol in the laboratory of Valiasr Hospital in Arak, six sterile drops are prepared. Control group: The left eye of patients will be considered as control group. In this group, routine care will be done on the eye. Exposure keratopathy. Timepoint: Examination of the eye before study, using fluorescein paper and ophthalmoscope with blue cobalt light filter, and then daily and at the beginning of each day. Method of measurement: The scale of corneal changes. Arak University of Medical Sciences Approved 2019-01-21 Ethics committee of Arak University of Medical Sciences Arak University of Medical Sciences, Basij Sq., Sardasht Region Arak Markazi Iran (Islamic Republic of)